BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36227332)

  • 1. Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress-induced cell death.
    Naradun N; Talabnin K; Ayuttha KIN; Talabnin C
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jan; 396(1):109-120. PubMed ID: 36227332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma.
    Vaeteewoottacharn K; Kariya R; Matsuda K; Taura M; Wongkham C; Wongkham S; Okada S
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1551-62. PubMed ID: 23877657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin Disrupts Proteasome Bounce-Back Effect through Suppressing ZEB1/Nfe2l1 in Cholangiocarcinoma.
    Xiang Y; Jia M; Gao Y; Yang F; Wang T; Dai R; Wang M; Miao H
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):106. PubMed ID: 38538281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway.
    Thongsom S; Suginta W; Lee KJ; Choe H; Talabnin C
    Apoptosis; 2017 Nov; 22(11):1473-1484. PubMed ID: 28913568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
    Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma.
    Chen M; Qian C; Jin B; Hu C; Zhang L; Wang M; Zhou B; Zuo W; Huang L; Wang Y
    Cancer Biol Ther; 2023 Dec; 24(1):2162807. PubMed ID: 36647192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.
    Chen MH; Chiang KC; Cheng CT; Huang SC; Chen YY; Chen TW; Yeh TS; Jan YY; Wang HM; Weng JJ; Chang PM; Liu CY; Li CP; Chao Y; Chen MH; Huang CY; Yeh CN
    Oncotarget; 2014 May; 5(9):2372-89. PubMed ID: 24796583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-125 induced cholangiocarcinoma cell death is enhanced by inhibition of endoplasmic reticulum stress-mediated protective autophagy.
    Zou L; Chang W; Bai JH; Shi WH; Jin Y; Wang JF; Wang KH
    Neoplasma; 2022 May; 69(3):620-629. PubMed ID: 35263996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells.
    Ustundag Y; Bronk SF; Gores GJ
    World J Gastroenterol; 2007 Feb; 13(6):851-7. PubMed ID: 17352013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of AGR2vH facilitates cholangiocarcinoma cell survival under endoplasmic reticulum stress via the activation of the unfolded protein response pathway.
    Suwanmanee G; Yosudjai J; Phimsen S; Wongkham S; Jirawatnotai S; Kaewkong W
    Int J Mol Med; 2020 Feb; 45(2):669-677. PubMed ID: 31894252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage.
    Yu W; Xiang Y; Luo G; Zhao X; Xiao B; Cheng Y; Feng C; Duan C; Xia X; Wong VKW; Dai R
    Cancer Biother Radiopharm; 2018 Aug; 33(6):258-265. PubMed ID: 29957018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines.
    Riantana H; Waenphimai O; Mahalapbutr P; Karnchanapandh K; Vaeteewoottacharn K; Wongkham S; Sawanyawisuth K
    Pathol Res Pract; 2023 Aug; 248():154678. PubMed ID: 37454493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma.
    Jiang TY; Pan YF; Wan ZH; Lin YK; Zhu B; Yuan ZG; Ma YH; Shi YY; Zeng TM; Dong LW; Tan YX; Wang HY
    Sci Transl Med; 2020 Sep; 12(562):. PubMed ID: 32967970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Chloroadenosine Induces ER Stress and Apoptotic Cell Death in Cholangiocarcinoma Cells.
    Lertsuwan J; Svasti J; Satayavivad J
    Anticancer Res; 2023 Dec; 43(12):5425-5436. PubMed ID: 38030206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.
    Chen Q; Li W; Wan Y; Xia X; Wu Q; Chen Y; Lai Z; Yu C; Li W
    Hepatology; 2012 Jun; 55(6):1820-9. PubMed ID: 22213475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells.
    Sato A; Asano T; Isono M; Ito K; Asano T
    BMC Urol; 2014 Aug; 14():71. PubMed ID: 25176354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic Acid Inhibits Glioblastoma Progression via Endoplasmic Reticulum Stress Related Apoptosis and Synergizes with the Proteasome Inhibitor Bortezomib.
    Yao Z; Zhang X; Zhao F; Wang S; Chen A; Huang B; Wang J; Li X
    ACS Chem Neurosci; 2020 May; 11(9):1337-1346. PubMed ID: 32239921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL Enhances Shikonin Induced Apoptosis through ROS/JNK Signaling in Cholangiocarcinoma Cells.
    Zhou G; Yang Z; Wang X; Tao R; Zhou Y
    Cell Physiol Biochem; 2017; 42(3):1073-1086. PubMed ID: 28662515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma.
    Ri M
    Int J Hematol; 2016 Sep; 104(3):273-80. PubMed ID: 27169614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.